Lv5
976 积分 2024-11-06 加入
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
7小时前
待确认
Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies
8小时前
待确认
Exploring the Role of Target Expression in Treatment Efficacy of Antibody–Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review
8小时前
待确认
P3.13D.01 Proteomic Characterization of Antibody Drug Conjugate Target Expression Profiles in Small Cell Lung Cancer (SCLC)
8小时前
待确认
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update
17小时前
已完结
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
17小时前
已完结
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer
1天前
已完结
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer
4天前
已完结
Cancer therapy with antibodies
4天前
已完结
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer
6天前
已完结
皖公网安备34019202002308
